UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration

The Annals of pharmacotherapy, 2009-10, Vol.43 (10), p.1583-1597

2009

Volltextzugriff (PDF)

Physician perceptions about generic drugs

The Annals of pharmacotherapy, 2011-01, Vol.45 (1), p.31-38

2011

Volltextzugriff (PDF)

The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines

Medical care research and review, 2021-10, Vol.78 (5), p.585-590

2021

Volltextzugriff (PDF)

Generic substitution of antiretrovirals: patients’ and health care providers’ opinions

International journal of STD & AIDS, 2017-10, Vol.28 (12), p.1239-1246

2017

Volltextzugriff (PDF)

Approximating Future Generic Entry for New Drugs

The Journal of law, medicine & ethics, 2019-03, Vol.47 (1), p.177-182

2019

Volltextzugriff (PDF)

The discovery and development of antiretroviral agents

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.5-14

2014

Volltextzugriff (PDF)

Policies and perceptions on generic drugs: The case of Greece

Health services management research, 2019-02, Vol.32 (1), p.49-56

2019

Volltextzugriff (PDF)

Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.15-29

2014

Volltextzugriff (PDF)

Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?

Journal of the International Association of Providers of AIDS Care, 2019-01, Vol.18, p.2325958218822304-2325958218822304

2019

Volltextzugriff (PDF)

Hyperinflation: Definitions and Causes

Journal of Pharmacy Practice, 2020-04, Vol.33 (2), p.183-186

2020

Volltextzugriff (PDF)

Simplification of antiretroviral therapy: a necessary step in the public health response to HIV/AIDS in resource-limited settings

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.31-37

2014

Volltextzugriff (PDF)

A Population-Based Study of the Use of Selective Serotonin Reuptake Inhibitors before and after Introduction of Generic Equivalents

Canadian journal of psychiatry, 2012-04, Vol.57 (4), p.223-229

2012

Volltextzugriff (PDF)

Production of antiretroviral drugs in middle- and low-income countries

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.49-55

2014

Volltextzugriff (PDF)

Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?

Journal of pharmacy practice, 2017-02, Vol.30 (1), p.9-16

2017

Volltextzugriff (PDF)

Regulatory framework for access to safe, effective quality medicines

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.69-77

2014

Volltextzugriff (PDF)

Prices paid for adult and paediatric antiretroviral treatment by low- and middle-income countries in 2012: high, low or just right?

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.39-47

2014

Volltextzugriff (PDF)

Generic substitution of antihypertensive drugs: does it affect adherence?

The Annals of pharmacotherapy, 2006-01, Vol.40 (1), p.15-20

2006

Volltextzugriff (PDF)

Intellectual property rights, market competition and access to affordable antiretrovirals

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.57-67

Pascual, Fernando

2014

Volltextzugriff (PDF)

Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan

Therapeutic innovation & regulatory science, 2018-07, Vol.52 (4), p.442-448

2018

Volltextzugriff (PDF)

Improving the assessment of prescribing: use of a 'substitution index'

Journal of health services research & policy, 2013-07, Vol.18 (3), p.138-143

2013

Volltextzugriff (PDF)

Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients

The Annals of pharmacotherapy, 2012-12, Vol.46 (12), p.1609-1616

2012

Volltextzugriff (PDF)

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

European journal of preventive cardiology, 2012-06, Vol.19 (3), p.474-483

2012

Volltextzugriff (PDF)

Hyperinflation—Definitions and Causes

Journal of pharmacy practice, 2018-08, Vol.31 (4), p.370-373

2018

Volltextzugriff (PDF)

Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.117-123

2014

Volltextzugriff (PDF)

The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles

The Annals of pharmacotherapy, 2010-04, Vol.44 (4), p.650-657

2010

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Aktive Filter

KollektionSAGE Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(135)

Sprache

Englisch
(135)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration

Physician perceptions about generic drugs

The Price to Consumers of Generic Pharmaceuticals: Beyond the Headlines

Generic substitution of antiretrovirals: patients’ and health care providers’ opinions

Approximating Future Generic Entry for New Drugs

The discovery and development of antiretroviral agents

Policies and perceptions on generic drugs: The case of Greece

Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey

Desimplification of Single Tablet Antiretroviral (ART) Regimens—A Practical Cost-Savings Strategy?

Hyperinflation: Definitions and Causes

Simplification of antiretroviral therapy: a necessary step in the public health response to HIV/AIDS in resource-limited settings

A Population-Based Study of the Use of Selective Serotonin Reuptake Inhibitors before and after Introduction of Generic Equivalents

Production of antiretroviral drugs in middle- and low-income countries

Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products?

Regulatory framework for access to safe, effective quality medicines

Prices paid for adult and paediatric antiretroviral treatment by low- and middle-income countries in 2012: high, low or just right?

Generic substitution of antihypertensive drugs: does it affect adherence?

Intellectual property rights, market competition and access to affordable antiretrovirals

Optimal Anti-cancer Drug Profiles for Effective Penetration of the Anti-cancer Drug Market by Generic Drugs in Japan

Improving the assessment of prescribing: use of a 'substitution index'

Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

Hyperinflation—Definitions and Causes

Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health

The nine-year sustained cost-containment impact of swiss pilot physicians-pharmacists quality circles

Aktive Filter

Suchergebnisse filtern